Skip to main content
. 2017 Dec 27;9(5):6201–6212. doi: 10.18632/oncotarget.23717

Table 3. PD-L1 score applied to tumor cells.

Score % of PD-L1+ tumor cells
0 0
1 1–9
2 10–39
3 >40